SPOTLIGHT: Investors fund vaccination programs


Japanese investors have snapped up a $223 million bond program to fund vaccination campaigns in developing countries. The idea is that the investors' money will be used to pay for the upfront costs of a campaign and they will be repaid as governments fund the programs. This is the first time that individual investors have bought into a vaccination bond program and it could prove a model for future fundraising efforts in other countries. FierceVaccines

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.